Life Science

IRA invests in Life Science/R&D facilities leased to pharmaceutical, biotech, medical device and genomics companies, as well as contract research organizations (CROs) and contract manufacturing organizations. Sustained biotech and pharma investment, technological advancements, and an aging population will continue to drive growth for Life Science. IRA seeks to capture this growing demand by targeting assets in strategic locations where leading research universities and medical institutions inspire innovation.

Featured Transaction

  • IRA acquired a 159,746 SF three-building office campus that was 100% leased to Glaukos Corporation (NYSE: GKOS).

  • Glaukos identified the site for a major renovation that would reposition the campus to serve as the Company’s in-house lab (Wet/Chem/Dry), supported by its administrative headquarters in buildings 2 & 3.

  • After Closing, IRA worked closely with Glaukos to facilitate the buildout of 28,000 SF of highly specialized lab space including nine clean rooms.

  • Additionally, the renovation included a a 1-acre park, cafeteria, gym, and conference rooms which helped transform the property into a top tier life science campus.